Fig. 4.  The effect of verapamil on levobupivacaine (LBV) concentration-response curve in the endothelium-denuded aorta. Data are shown as mean ± SD and are expressed as a percentage of the maximal contraction induced by isotonic 60 mM KCl (100% = 3.61 ± 0.71 g [n = 6], 100 = 3.12 ± 0.49 g [n = 6], and 100% = 3.16 ± 0.39 g [n = 6] for endothelium-denuded aorta with no drug, 10−7M verapamil, and 5 × 10−7M verapamil, respectively). N indicates the number of rats from which descending thoracic aortic rings were derived. Verapamil (10−7M): *P = 0.0027 versus  no drug at 10−5M LBV; ‡P = 0.0108 versus  no drug at 3 × 10−4M LBV. †P < 0.001 versus  no drug.

Fig. 4.  The effect of verapamil on levobupivacaine (LBV) concentration-response curve in the endothelium-denuded aorta. Data are shown as mean ± SD and are expressed as a percentage of the maximal contraction induced by isotonic 60 mM KCl (100% = 3.61 ± 0.71 g [n = 6], 100 = 3.12 ± 0.49 g [n = 6], and 100% = 3.16 ± 0.39 g [n = 6] for endothelium-denuded aorta with no drug, 10−7M verapamil, and 5 × 10−7M verapamil, respectively). N indicates the number of rats from which descending thoracic aortic rings were derived. Verapamil (10−7M): *P = 0.0027 versus  no drug at 10−5M LBV; ‡P = 0.0108 versus  no drug at 3 × 10−4M LBV. †P < 0.001 versus  no drug.

Close Modal

or Create an Account

Close Modal
Close Modal